Cherry Creek Investment Advisors, Inc. Bio Techne Corp Transaction History

Cherry Creek Investment Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$52.83 - $78.22 $4,067 - $6,022	-77 Reduced 2.51%	2,995 $231,000
Q3 2023 Oct 13, 2023	SELL	$67.52 - $89.42 $4,996 - $6,617	-74 Reduced 2.35%	3,072 $209,000
Q2 2023 Jul 14, 2023	BUY	$73.76 - $85.98 $147 - $171	2 Added 0.06%	3,146 $256,000
Q1 2023 Apr 24, 2023	BUY	$71.62 - $86.62 $143 - $173	2 Added 0.06%	3,144 $233,000
Q4 2022 Feb 10, 2023	BUY	$80.67 - $352.29 $190,058 - $829,995	2,356 Added 299.75%	3,142 $260,000
Q3 2022 Oct 24, 2022	BUY	$282.54 - $391.85 $282 - $391	1 Added 0.13%	786 $223,000
Q1 2022 Apr 22, 2022	BUY	$353.85 - $487.79 $277,772 - $382,915	785 New	785 $340,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.96B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Cherry Creek Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Cherry Creek Investment Advisors, Inc. with notifications on news.